News

Published on 31 May 2024 on Benzinga

Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...

Article preview image

On Friday, Pfizer Inc PFE released longer-term follow-up results from the Phase 3 CROWN trial evaluating Lorbrena (lorlatinib) available in Europe as Lorviqua versus Xalkori (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

Also Read: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac.

Read the rest of the article
NYSE.PFE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Dow Surges 250 Points; MongoDB Shares Plummet - MongoDB (NASDAQ:MDB)

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 250 p...

Benzinga 31 May 2024
How To Earn $500 A Month From Pfizer Stock

How To Earn $500 A Month From Pfizer Stock Shares of Pfizer Inc. (NYSE:PFE) closed higher during ...

Benzinga via Yahoo Finance 31 May 2024
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...

On Friday, Pfizer Inc PFE released longer-term follow-up results from the Phase 3 CROWN trial eva...

Benzinga 31 May 2024
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)

On CNBC's “Mad Money Lightning Round,” Jim Cramer called Celestica Inc. CLS “terrific” after the ...

Benzinga 28 May 2024
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend...

During times of turbulence and uncertainty in the markets, even when markets are at all-time high...

Benzinga 28 May 2024
Why Is Sarepta Therapeutics Stock Trading Lower On Tuesday? - Sarepta Therapeutics (NASDAQ:SRPT)

RBC Capital Markets has downgraded Sarepta Therapeutics Inc SRPT as it weighs recent investor fee...

Benzinga 28 May 2024
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...

Zacks via Yahoo Finance 28 May 2024
This Biotech Stock is a “Strong Buy” According to Raymond James

We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this articl...

Insider Monkey via Yahoo Finance 27 May 2024
Hedge Funds are Racking Up Shares of This Healthcare Stock

We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this articl...

Insider Monkey via Yahoo Finance 27 May 2024
Invest $50k In This Stock To Become A Dividend Millionaire In 10 Years

Invest $50k In This Stock To Become A Dividend Millionaire In 10 Years Benzinga and Yahoo Finance...

Benzinga via Yahoo Finance 24 May 2024

Copyright Statfolio @ 2024

Social Accounts